K. A. Smith

The Pulmonary Hypertension Consult: Clinical and Coding Considerations.

J. Fritz, K. A. Smith, Jason S. Fritz, 2016, Chest.

Lower DHEA-S levels predict disease and worse outcomes in post-menopausal women with idiopathic, connective tissue disease- and congenital heart disease-associated pulmonary arterial hypertension

D. Bluemke, R. Barr, J. Lima, 2018, European Respiratory Journal.

BMI and Treatment Response in Patients With Pulmonary Arterial Hypertension

Breanne E. McCarthy, H. Palevsky, R. McClelland, 2022, Chest.

Anastrozole in Pulmonary Arterial Hypertension. A Randomized, Double‐Blind, Placebo‐controlled Trial

H. Palevsky, A. DeMichele, K. Propert, 2016, American journal of respiratory and critical care medicine.

Physical Activity and Symptoms in Pulmonary Arterial Hypertension.

H. Palevsky, M. Sommers, H. Shou, 2016, Chest.

Are Hemodynamics Surrogate End Points in Pulmonary Arterial Hypertension?

H. Palevsky, S. Halpern, Nicole B Gabler, 2014, Circulation.

Supplemental Material Are Hemodynamics Surrogate Endpoints in Pulmonary Arterial Hypertension ?

H. Palevsky, S. Halpern, Nicole B Gabler, 2014 .

Fulvestrant for the Treatment of Pulmonary Arterial Hypertension.

D. Mankoff, H. Palevsky, A. DeMichele, 2019, Annals of the American Thoracic Society.

Secular and Regional Trends among Pulmonary Arterial Hypertension Clinical Trial Participants.

H. Palevsky, R. McClelland, R. Urbanowicz, 2021, Annals of the American Thoracic Society.